-
All Blacks name veteran Taylor captain as Mo'unga seizes 10 jersey
-
8.3 mn refugees at risk due to 'severe' funding cuts: UN
-
Race against time as Asian Games cricket quarter-finals washed out
-
Stocks drop and oil rises as Hormuz hopes fade
-
India turns to corals and seagrass to shield against rising seas
-
OpenAI cancels release of newest model due to safety concerns
-
Manchester City's Premier League charges: What comes next?
-
AI bosses head to White House as safety pressure builds
-
Brazil's cellphone crime: a security nightmare in every pocket
-
Batista sacked as Costa Rica coach after six months
-
Russia pummels Kyiv in latest deadly attack
-
Flooding, power cuts and evacuations as Hurricane Polo slams Mexico
-
NFL Giants obtain QB McCarthy from Vikings
-
Dodgers eye three-peat, Red Sox face Yankees as MLB playoffs begin
-
Deal for evicted Spanish pensioner as PM seeks new housing law
-
Certification of Boeing 737 MAX delayed by software bug
-
Clippers apologize, warn fans of 'challenges' after Leonard scandal
-
Celine Dion wows Paris Fashion Week with surprise gig
-
Turkish comedian convicted for Erdogan 'insult' freed pending appeal
-
AMD buys firm founded by AI 'godmother' Fei-Fei Li
-
Trump announces 'biggest' US steel plant in battleground Iowa
-
Italy rebound in Turkey as France win late in Belgium
-
Olise wonder strike gives Zidane's France win in Belgium
-
Pope says concerns about AI 'should be taken seriously'
-
US stocks fall, bond yields rise as Middle East war drags on
-
Hurricanes to hoist title banner as NHL season begins
-
Trump denies offering to sell arms to China's Xi
-
Justice Alito steps aside from major US climate case
-
Wemby ready for NBA Spurs to move rivals in climb to top
-
Willis happy with England exile after retains Top 14 player award
-
Ukraine to postpone some spending amid delays in aid: PM
-
Spain housing protests keep heat on government as PM seeks new law
-
Tuchel says Czech Republic game 'not yet a must-win'
-
Wissa spoils Zimbabwe homecoming as DR Congo win AFCON qualifier
-
MaXhosa puts South Africa on the Paris fashion map
-
UK police release on bail five men held over airbase incident
-
Rose, Scott among 2027 World Golf Hall of Fame finalists
-
Ex-All Black Plummer 'sure' New Zealand will find Super Rugby solution
-
Brunson says NBA champion Knicks can't get satisfaction
-
Shein sees 1% revenue growth in first half of 2026
-
France puts out largest wildfire since 1949
-
Netherlands regrets Israel retaliation in settlements row
-
Real Madrid's Perez summoned over Barcelona referee payments comments
-
Moscow seizes Russian assets of German food retailer Metro
-
Oil takes off again, Wall Street dips after Trump rejects Iran truce offer
-
Bulgarian spirits inflamed by new rakia rules
-
AlgoQuant Asset Management Selects Liquid Mercury to Enhance Digital Asset Trading Infrastructure
-
Documentary turns camera on architect Peter Zumthor
-
UK to reopen refugee resettlement scheme to push 'safe' migration
-
UK police say releasing on bail five men held over airbase incident
Who should get paid for nature's sequenced genes?
Much of the vanilla that flavors our ice cream today is artificial, derived from the genetic signature of a plant that hundreds of years ago was known only to an Indigenous Mexican tribe.
The plant's sequenced genomic information, available on public databases, was used as the basis for a synthetic flavoring that today competes with vanilla grown in several countries, mainly by small-scale farmers.
Few, if any, benefits of the lucrative scientific advance have trickled down to the communities that gave us vanilla in the first place.
"Wild genetic resources and pharmaceuticals ... are a multi-multi-billion dollar businesses. They clearly are profitable... that's not in dispute," Charles Barber of the World Resources Institute think tank told AFP.
"A great deal of really valuable information has fed into the system from research and utilization of wild genetic resources. And there is no mechanism currently to compensate the people where this information is coming from" in the form of digitally sequenced data, he added.
Much of the information comes from poor countries.
Fair sharing of the gains derived from digitally-stored genetic sequencing data has been a headache for negotiators at the COP16 biodiversity summit into its second week in Cali, Colombia.
At the last conference, in Montreal in 2022, 196 country parties to the UN's Convention on Biological Diversity (CBD) agreed to create a benefit-sharing mechanism for the use of digital sequence information (DSI).
Two years later, they still need to resolve such basic questions as who pays, how much, into which fund, and to whom does the money go?
- 'Cheap and very fast' -
The issue is a complex one.
There is little debate that genetic data-sharing on mostly free-access platforms is crucial for human advancement through medicine and vaccine development, for example.
But how to quantify the value of the sequenced information itself? And should the first people to discover a plant's particular usefulness be compensated?
"Sequencing technology has become so advanced that you can go with a... handheld device a little bit bigger than a cell phone and you can literally sequence a genome in an hour or two and upload it as you sequence it," Pierre du Plessis, a DSI expert and former negotiator for African countries at the CBD told AFP.
These gene sequences are then uploaded to databases which artificial intelligence can mine for potential leads for product development.
DSI is worth an estimated hundreds of billions of dollars a year. And there is a lot of it out there.
"Once the sequence is put into a public database, generally, no benefit-sharing obligations apply," Nithin Ramakrishnan, a researcher with the Third World Network, an advocacy NGO for developing countries, told AFP in Cali.
"Like when the sandalwood sequence information is available in the database whether India wants to share its sandalwood... with a cosmetic company or not, doesn't matter.
- Mandatory -
A point of contention in Cali is a demand from developing countries that payment for DSI use be mandatory, perhaps through a one-percent levy on profits from drugs, cosmetics or other products.
They also want guarantees of non-monetary benefits such as access to vaccines produced from genetic information sequenced from viruses and other pathogens.
"We want real understanding, sector-specific understanding of what non-monetary benefits will be shared and we want the system to be obligatory -- the users should have some form of obligation to share benefits," said Ramakrishnan.
Another sticking point is access for Indigenous people and local communities to DSI funds.
Developing countries want the information on genetic databases to be traceable and "answerable to governments" of the countries where it comes from, said Ramakrishnan.
But rich nations and many researchers oppose such a model which they fear will be too onerous, potentially putting the brakes on scientific pursuits that could benefit all humankind.
With such divergent points of view, observers are doubtful the Cali COP will emerge with any firm decisions on the outstanding questions by closing time on Friday.
The World Wildlife Fund has said "many more rounds of negotiations appear necessary" on DSI.
Added Barber: "I think it's not going to all get solved here."
B.Khalifa--SF-PST